MATTHEW POWELL: Open Payments
NPI 1154316222 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 118 payments from 21 companies in 2025. Trend: 2023 $1,673 · 2024 $2,185 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $346 |
| ABBVIE INC. | 30 | $322 |
| Novo Nordisk Inc | 15 | $274 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $199 |
| Stryker Corporation | 1 | $175 |
| GlaxoSmithKline, LLC. | 16 | $169 |
| PFIZER INC. | 11 | $165 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Amgen Inc. | 2 | $33 |
Products named: Ozempic, PANGEA, QULIPTA, AIRSUPRA, BREZTRI, JARDIANCE, TRELEGY ELLIPTA, UBRELVY.
Industry payments across MI — which companies pay providers there.
